Management of the Malignant Middle Cerebral Artery Syndrome

Abstract

The malignant middle cerebral artery syndrome, characterized by cerebral edema following large anterior circulation ischemic stroke, is a disease entity with high morbidity and mortality that is easy to recognize, but challenging to manage. In this review, we begin by discussing important aspects of the clinical presentation of the syndrome, including risk factors for deterioration. We then discuss medical measures that can be undertaken before symptomatic cerebral edema occurs and then outline both medical and surgical options for subsequent neurologic worsening. Shared decision making with patients' surrogates regarding decompressive craniectomy in the setting of available clinical trial data is addressed. The authors conclude with a brief discussion of promising novel therapies for preventing cerebral edema.

Keywords

middle cerebral artery - stroke - brain edema - decompressive craniectomy - decision making

• References

• 1 Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996; 53 (4) 309-315
• 2 Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol 2007; 6 (3) 258-268
• 3 Frank JI. Large hemispheric infarction, deterioration, and intracranial pressure. Neurology 1995; 45 (7) 1286-1290
• 4 Kasner SE, Demchuk AM, Berrouschot J , et al. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke 2001; 32 (9) 2117-2123
• 5 Walcott BP, Miller JC, Kwon CS , et al. Outcomes in severe middle cerebral artery ischemic stroke. Neurocrit Care 2013;
• 6 Larach DR, Larach DB, Larach MG. A life worth living: seven years after craniectomy. Neurocrit Care 2009; 11 (1) 106-111
• 7 Benejam B, Sahuquillo J, Poca MA , et al. Quality of life and neurobehavioral changes in survivors of malignant middle cerebral artery infarction. J Neurol 2009; 256 (7) 1126-1133
• 8 Kimberly WT, Sheth KN. Approach to severe hemispheric stroke. Neurology 2011; 76 (7) (Suppl. 02) S50-S56
• 9 Ropper AH. Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N Engl J Med 1986; 314 (15) 953-958
• 10 Cucchiara BL, Kasner SE, Wolk DA , et al; CLASS-I Investigators. Early impairment in consciousness predicts mortality after hemispheric ischemic stroke. Crit Care Med 2004; 32 (1) 241-245
• 11 Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke 1999; 30 (2) 287-292
• 12 Blacker DJ, Wijdicks EF. Delayed complete bilateral ptosis associated with massive infarction of the right hemisphere. Mayo Clin Proc 2003; 78 (7) 836-839
• 13 Qureshi AI, Suarez JI, Yahia AM , et al. Timing of neurologic deterioration in massive middle cerebral artery infarction: a multicenter review. Crit Care Med 2003; 31 (1) 272-277
• 14 Thomalla G, Hartmann F, Juettler E , et al; Clinical Trial Net of the German Competence Network Stroke. Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: a prospective multicenter observational study. Ann Neurol 2010; 68 (4) 435-445
• 15 Wijdicks EF, Diringer MN. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc 1998; 73 (9) 829-836
• 16 Jaramillo A, Góngora-Rivera F, Labreuche J, Hauw JJ, Amarenco P. Predictors for malignant middle cerebral artery infarctions: a postmortem analysis. Neurology 2006; 66 (6) 815-820
• 17 Jauch EC, Saver JL, Adams Jr HP , et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44 (3) 870-947
• 18 European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25 (5) 457-507
• 19 Seder DB, Riker RR, Jagoda A, Smith WS, Weingart SD. Emergency neurological life support: airway, ventilation, and sedation. Neurocrit Care 2012; 17 (Suppl. 01) S4-S20
• 20 Bhardwaj A, Harukuni I, Murphy SJ , et al. Hypertonic saline worsens infarct volume after transient focal ischemia in rats. Stroke 2000; 31 (7) 1694-1701
• 21 Simard JM, Sahuquillo J, Sheth KN, Kahle KT, Walcott BP. Managing malignant cerebral infarction. Curr Treat Options Neurol 2011; 13 (2) 217-229
• 22 Schwab S, Aschoff A, Spranger M, Albert F, Hacke W. The value of intracranial pressure monitoring in acute hemispheric stroke. Neurology 1996; 47 (2) 393-398
• 23 Poca MA, Benejam B, Sahuquillo J , et al. Monitoring intracranial pressure in patients with malignant middle cerebral artery infarction: is it useful?. J Neurosurg 2010; 112 (3) 648-657
• 24 Qizilbash N, Lewington SL, Lopez-Arrieta JM. Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev 2002; (2) CD000064
• 25 van Tuijl JH, van Raak EP, de Krom MC, Lodder J, Aldenkamp AP. Early treatment after stroke for the prevention of late epileptic seizures: a report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis. Seizure 2011; 20 (4) 285-291
• 26 Silverman IE, Restrepo L, Mathews GC. Poststroke seizures. Arch Neurol 2002; 59 (2) 195-201
• 27 Ropper AH. Hyperosmolar therapy for raised intracranial pressure. N Engl J Med 2012; 367 (8) 746-752
• 28 García-Morales EJ, Cariappa R, Parvin CA, Scott MG, Diringer MN. Osmole gap in neurologic-neurosurgical intensive care unit: its normal value, calculation, and relationship with mannitol serum concentrations. Crit Care Med 2004; 32 (4) 986-991
• 29 Toung TJ, Hurn PD, Traystman RJ, Bhardwaj A. Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline. Crit Care Med 2002; 30 (3) 644-649
• 30 Stocchetti N, Maas AI, Chieregato A, van der Plas AA. Hyperventilation in head injury: a review. Chest 2005; 127 (5) 1812-1827
• 31 Marion DW, Puccio A, Wisniewski SR , et al. Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit Care Med 2002; 30 (12) 2619-2625
• 32 Guluma KZ, Oh H, Yu SW, Meyer BC, Rapp K, Lyden PD. Effect of endovascular hypothermia on acute ischemic edema: morphometric analysis of the ICTuS trial. Neurocrit Care 2008; 8 (1) 42-47
• 33 Smith DS, Rehncrona S, Siesjö BK. Barbiturates as protective agents in brain ischemia and as free radical scavengers in vitro. Acta Physiol Scand Suppl 1980; 492: 129-134
• 34 Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB ; HAMLET investigators. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery Infarction with Life-Threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009; 8 (4) 326-333
• 35 Jüttler E, Schwab S, Schmiedek P , et al; DESTINY Study Group. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY). a randomized, controlled trial. . Stroke 2007; 38 (9) 2518-2525
• 36 Vahedi K, Vicaut E, Mateo J , et al; DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke 2007; 38 (9) 2506-2517
• 37 Vahedi K, Hofmeijer J, Juettler E , et al; DECIMAL, DESTINY, and HAMLET investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6 (3) 215-222
• 38 Jüttler E, Bösel J, Amiri H , et al; DESTINY II Study Group. DESTINY II: DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY II. Int J Stroke 2011; 6 (1) 79-86
• 39 Keller DM. Decompressive surgery improves older stroke patient survival. Medscape Medical News. Available at: http://www.medscape.com/viewarticle/773737 . Accessed September 30, 2013
• 40 Kelly AG, Holloway RG. Health state preferences and decision-making after malignant middle cerebral artery infarctions. Neurology 2010; 75 (8) 682-687
• 41 Kilincer C, Asil T, Utku U , et al. Factors affecting the outcome of decompressive craniectomy for large hemispheric infarctions: a prospective cohort study. Acta Neurochir (Wien) 2005; 147 (6) 587-594 , discussion 594
• 42 Rahme R, Zuccarello M, Kleindorfer D, Adeoye OM, Ringer AJ. Decompressive hemicraniectomy for malignant middle cerebral artery territory infarction: is life worth living?. J Neurosurg 2012; 117 (4) 749-754
• 43 Mori K, Nakao Y, Yamamoto T, Maeda M. Early external decompressive craniectomy with duroplasty improves functional recovery in patients with massive hemispheric embolic infarction: timing and indication of decompressive surgery for malignant cerebral infarction. Surg Neurol 2004; 62 (5) 420-429 , discussion 429–430
• 44 Chen C, Carter BS. Hemicraniectomy for massive cerebral infarction. Top Stroke Rehabil 2004; 11 (2) 7-11
• 45 Manawadu D, Quateen A, Findlay JM. Hemicraniectomy for massive middle cerebral artery infarction: a review. Can J Neurol Sci 2008; 35 (5) 544-550
• 46 Curry Jr WT, Sethi MK, Ogilvy CS, Carter BS. Factors associated with outcome after hemicraniectomy for large middle cerebral artery territory infarction. Neurosurgery 2005; 56 (4) 681-692 , discussion 681–692
• 47 Chen M, Simard JM. Cell swelling and a nonselective cation channel regulated by internal Ca2+ and ATP in native reactive astrocytes from adult rat brain. J Neurosci 2001; 21 (17) 6512-6521
• 48 Chen M, Dong Y, Simard JM. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. J Neurosci 2003; 23 (24) 8568-8577
• 49 Simard JM, Chen M, Tarasov KV , et al. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med 2006; 12 (4) 433-440
• 50 Simard JM, Tsymbalyuk N, Tsymbalyuk O, Ivanova S, Yurovsky V, Gerzanich V. Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke. Stroke 2010; 41 (3) 531-537
• 51 Thomalla GJ, Kucinski T, Schoder V , et al. Prediction of malignant middle cerebral artery infarction by early perfusion- and diffusion-weighted magnetic resonance imaging. Stroke 2003; 34 (8) 1892-1899
• 52 Sheth KN, Kimberly WT, Elm J , et al. GAMES (Glyburide Advantage in Malignant Edema and Stroke) pilot study [abstract]. Abstract presented at: International Stroke Conference; February 6, 2013; Honolulu, HI
• 53 Zador Z, Stiver S, Wang V, Manley GT. Role of aquaporin-4 in cerebral edema and stroke. In: Beitz E, , ed. Handbook of Experimental Pharmacology. Berlin, Germany: Springer-Verlag; 2009: 159-170
• 54 Manley GT, Fujimura M, Ma T , et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000; 6 (2) 159-163
• 55 Yang B, Zador Z, Verkman AS. Glial cell aquaporin-4 overexpression in transgenic mice accelerates cytotoxic brain swelling. J Biol Chem 2008; 283 (22) 15280-15286
• 56 Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 2004; 18 (11) 1291-1293
• 57 Migliati ER, Amiry-Moghaddam M, Froehner SC, Adams ME, Ottersen OP, Bhardwaj A. Na(+)-K (+)-2Cl (-) cotransport inhibitor attenuates cerebral edema following experimental stroke via the perivascular pool of aquaporin-4. Neurocrit Care 2010; 13 (1) 123-131
• 58 Bhattacharya P, Pandey AK, Paul S, Patnaik R, Yavagal DR. Aquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rodents. PLoS ONE 2013; 8 (9) e73481
• 59 Li M, Ma RN, Li LH, Qu YZ, Gao GD. Astragaloside IV reduces cerebral edema post-ischemia/reperfusion correlating the suppression of MMP-9 and AQP4. Eur J Pharmacol 2013; 715 (1-3) 189-195
• 60 Yang D, Li SY, Yeung CM , et al. Lycium barbarum extracts protect the brain from blood-brain barrier disruption and cerebral edema in experimental stroke. PLoS ONE 2012; 7 (3) e33596
• 61 Shin JA, Choi JH, Choi YH, Park EM. Conserved aquaporin 4 levels associated with reduction of brain edema are mediated by estrogen in the ischemic brain after experimental stroke. Biochim Biophys Acta 2011; 1812 (9) 1154-1163